CAV1 and gastric cancer: To verify the anticancer effect of CQ in CAV1-positive SEM-type GC under more physiological conditions, we first generated patient-derived organoids from SFRP4-high (SEM-type) and SFRP4-low (non-SEM-type) tumors from GC patients1 (Fig. 5a).